[DPHARMA] QoQ Cumulative Quarter Result on 31-Dec-2020 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Feb-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- 38.18%
YoY- 6.04%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 493,731 321,893 166,454 569,902 435,816 302,044 158,713 112.95%
PBT 65,856 43,373 23,176 76,157 55,686 37,118 17,727 139.67%
Tax -15,889 -10,369 -5,562 -17,547 -13,269 -8,828 -4,166 143.91%
NP 49,967 33,004 17,614 58,610 42,417 28,290 13,561 138.36%
-
NP to SH 49,967 33,004 17,614 58,610 42,417 28,290 13,561 138.36%
-
Tax Rate 24.13% 23.91% 24.00% 23.04% 23.83% 23.78% 23.50% -
Total Cost 443,764 288,889 148,840 511,292 393,399 273,754 145,152 110.50%
-
Net Worth 612,147 614,350 635,424 642,484 584,565 581,725 540,662 8.62%
Dividend
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Div 4,708 3,530 - 45,891 3,479 3,421 - -
Div Payout % 9.42% 10.70% - 78.30% 8.20% 12.10% - -
Equity
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Net Worth 612,147 614,350 635,424 642,484 584,565 581,725 540,662 8.62%
NOSH 941,765 706,330 706,026 706,026 706,026 684,383 684,383 23.69%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 10.12% 10.25% 10.58% 10.28% 9.73% 9.37% 8.54% -
ROE 8.16% 5.37% 2.77% 9.12% 7.26% 4.86% 2.51% -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 52.43 45.58 23.58 80.72 62.63 44.13 23.19 72.17%
EPS 5.31 4.67 2.49 8.46 6.16 4.13 1.98 92.91%
DPS 0.50 0.50 0.00 6.50 0.50 0.50 0.00 -
NAPS 0.65 0.87 0.90 0.91 0.84 0.85 0.79 -12.18%
Adjusted Per Share Value based on latest NOSH - 706,026
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 51.33 33.46 17.30 59.24 45.31 31.40 16.50 112.95%
EPS 5.19 3.43 1.83 6.09 4.41 2.94 1.41 138.20%
DPS 0.49 0.37 0.00 4.77 0.36 0.36 0.00 -
NAPS 0.6364 0.6387 0.6606 0.6679 0.6077 0.6047 0.5621 8.62%
Price Multiplier on Financial Quarter End Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 -
Price 1.81 3.03 2.75 3.38 3.16 1.62 1.39 -
P/RPS 3.45 6.65 11.66 4.19 5.05 3.67 5.99 -30.75%
P/EPS 34.11 64.83 110.23 40.72 51.84 39.19 70.15 -38.13%
EY 2.93 1.54 0.91 2.46 1.93 2.55 1.43 61.24%
DY 0.28 0.17 0.00 1.92 0.16 0.31 0.00 -
P/NAPS 2.78 3.48 3.06 3.71 3.76 1.91 1.76 35.59%
Price Multiplier on Announcement Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 18/11/21 17/08/21 03/05/21 22/02/21 12/11/20 13/08/20 18/05/20 -
Price 1.62 2.49 2.93 3.42 4.04 3.15 1.72 -
P/RPS 3.09 5.46 12.43 4.24 6.45 7.14 7.42 -44.20%
P/EPS 30.53 53.28 117.44 41.20 66.28 76.20 86.80 -50.14%
EY 3.28 1.88 0.85 2.43 1.51 1.31 1.15 100.98%
DY 0.31 0.20 0.00 1.90 0.12 0.16 0.00 -
P/NAPS 2.49 2.86 3.26 3.76 4.81 3.71 2.18 9.25%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment